Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Ropacki, S. A. Articles by Jeste, D. V. Search for Related Content PubMed Citation Articles by Ropacki, S. A. Articles by Jeste, D. V. Alzheimer's Disease Epidemiology

Epidemiology of and Risk Factors for Psychosis of Alzheimer’s Disease: A Review of 55 Studies Published From 1990 to 2003

OBJECTIVE: The authors reviewed studies published between 1990 and 2003 that reported the prevalence, incidence, and persistence of, as well as the risk factors associated with, psychosis of Alzheimer’s disease. METHOD: PubMed and PsycINFO databases were searched by using the terms "psychosis and Alzheimer disease" and "psychosis and dementia." Empirical investigations presenting quantitative data on the epidemiology of and/or risk factors for psychotic symptoms in Alzheimer’s disease were included in the review. A total of 55 studies, including a total of 9,749 subjects, met the inclusion criteria. RESULTS: Psychosis was reported in 41% of patients with Alzheimer’s disease, including delusions in 36% and hallucinations in 18%. The incidence of psychosis increased progressively over the first 3 years of observation, after which the incidence seemed to plateau. Psychotic symptoms tended to last for several months but became less prominent after 1 year. African American or black ethnicity and more severe cognitive impairment were associated with a higher rate of psychosis. Psychosis was also associated with more rapid cognitive decline. Some studies found a significant association between psychosis and age, age at onset of Alzheimer’s disease, and illness duration. Gender, education, and family history of dementia or psychiatric illness showed weak or inconsistent relationships with psychosis. CONCLUSIONS: Psychotic symptoms are common and persistent in patients with Alzheimer’s disease. Improved methods have advanced the understanding of psychosis in Alzheimer’s disease, although continued research, particularly longitudinal studies, may unveil biological and clinical associations that will inform treatments for these problematic psychological disturbances.

This article has been cited by other articles:

				G. M. Savva, J. Zaccai, F. E. Matthews, J. E. Davidson, I. McKeith, C. Brayne, and the Medical Research Council Cognitive Function an Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population The British Journal of Psychiatry, March 1, 2009; 194(3): 212 - 219. [Abstract] [Full Text] [PDF]

				S. Reeves, R. Brown, R. Howard, and P. Grasby Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease Neurology, February 10, 2009; 72(6): 528 - 534. [Abstract] [Full Text] [PDF]

				H. H. Kyomen and T. H. Whitfield Psychosis in the Elderly Am J Psychiatry, February 1, 2009; 166(2): 146 - 150. [Full Text] [PDF]

				J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., November 1, 2008; 30(1): 15 - 34. [Abstract] [Full Text] [PDF]

				D. L. Sultzer, S. M. Davis, P. N. Tariot, K. S. Dagerman, B. D. Lebowitz, C. G. Lyketsos, R. A. Rosenheck, J. K. Hsiao, J. A. Lieberman, L. S. Schneider, et al. Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer's Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial Am J Psychiatry, July 1, 2008; 165(7): 844 - 854. [Abstract] [Full Text] [PDF]

				H. C. Kales, M. Valenstein, H. M. Kim, J. F. McCarthy, D. Ganoczy, F. Cunningham, and F. C. Blow Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications Am J Psychiatry, October 1, 2007; 164(10): 1568 - 1576. [Abstract] [Full Text] [PDF]

				D. V. Jeste, T. W. Meeks, D. S. Kim, and G. S. Zubenko Research Agenda for DSM-V: Diagnostic Categories and Criteria for Neuropsychiatric Syndromes in Dementia J Geriatr Psychiatry Neurol, September 1, 2006; 19(3): 160 - 171. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us